Y. Du

Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.

G. Cao, J. Yin, F. Lu, 2014, Annals of Oncology.

Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis.

G. Cao, W. B. Liu, Y. Du, 2015, Current oncology.

Systemic Radiotherapy of Bone Metastases With Radionuclides.

I. Murray, Y. Du, Y. Du, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer.

N. deSouza, T. Yap, F. McDonald, 2016, European journal of cancer.

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

Jun Yao, G. Hortobagyi, L. Nie, 2017, Oncogene.

Metformin plus megestrol acetate compared with megestrol acetate alone as fertility‐sparing treatment in patients with atypical endometrial hyperplasia and well‐differentiated endometrial cancer: a randomised controlled trial

J. Liu, C. Ning, J. Guan, 2020, BJOG : an international journal of obstetrics and gynaecology.

1027MO ALKS 4230 monotherapy and in combination with pembrolizumab (pembro) in patients (pts) with refractory solid tumours (ARTISTRY-1)

H. Hirte, V. Velcheti, M. Ernstoff, 2020 .